BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7940 related articles for article (PubMed ID: 2184980)

  • 1. Immunohistochemistry in surgical pathology. The case of the undifferentiated malignant neoplasm.
    Linder J
    Clin Lab Med; 1990 Mar; 10(1):59-76. PubMed ID: 2184980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues.
    Cartun RW; Coles FB; Pastuszak WT
    Am J Pathol; 1987 Dec; 129(3):415-21. PubMed ID: 3322020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.
    Hsu FD; Nielsen TO; Alkushi A; Dupuis B; Huntsman D; Liu CL; van de Rijn M; Gilks CB
    Mod Pathol; 2002 Dec; 15(12):1374-80. PubMed ID: 12481020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray.
    Abrahams NA; MacLennan GT; Khoury JD; Ormsby AH; Tamboli P; Doglioni C; Schumacher B; Tickoo SK
    Histopathology; 2004 Dec; 45(6):593-602. PubMed ID: 15569050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cytokeratins and additional markers in undifferentiated lymph node metastases of the neck.
    Bartel-Friedrich S; Friedrich RE; Holzhausen HJ
    Anticancer Res; 2000; 20(6D):4931-40. PubMed ID: 11326642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies marking B-cell non-Hodgkin's lymphoma in paraffin-embedded tissue.
    Linder J; Ye Y; Armitage JO; Weisenburger DD
    Mod Pathol; 1988 Jan; 1(1):29-34. PubMed ID: 3266335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intermediate filament proteins as markers in tumor diagnosis].
    Altmannsberger M
    Veroff Pathol; 1988; 127():1-105. PubMed ID: 3341148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD45 (leukocyte common antigen) immunoreactivity in metastatic undifferentiated and neuroendocrine carcinoma: a potential diagnostic pitfall.
    Nandedkar MA; Palazzo J; Abbondanzo SL; Lasota J; Miettinen M
    Mod Pathol; 1998 Dec; 11(12):1204-10. PubMed ID: 9872653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study.
    Argenyi ZB; Cain C; Bromley C; Nguyen AV; Abraham AA; Kerschmann R; LeBoit PE
    Am J Dermatopathol; 1994 Jun; 16(3):233-40. PubMed ID: 7943629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
    Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
    Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratin protein immunohistochemistry in surgical pathology practice.
    Corson JM
    Pathol Annu; 1986; 21 Pt 2():47-81. PubMed ID: 2427996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear cell sarcoma. An immunohistochemical analysis of six cases and comparison with other epithelioid neoplasms of soft tissue.
    Swanson PE; Wick MR
    Arch Pathol Lab Med; 1989 Jan; 113(1):55-60. PubMed ID: 2521288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemically detecting target antigens in patient biopsies for tailoring monoclonal antibody based cancer therapy.
    Smith NL; Finley JL; Wennerberg AE; Semer DA; Kearse KP
    Hum Antibodies; 1999; 9(1):61-5. PubMed ID: 10331187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical phenotyping of malignant melanoma. A procedure whose time has come in pathology practice.
    Duray PH; Ernstoff MS; Titus-Ernstoff L
    Pathol Annu; 1990; 25 Pt 2():351-77. PubMed ID: 2202965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of routinely processed anaplastic large cell tumours with a small panel of antibodies. An immunohistochemical study with clinical follow-up.
    Henzen-Logmans SC; Mullink H; Vennegoor C; Hilgers J; Oort J; Meijer CJ
    Histol Histopathol; 1987 Apr; 2(2):107-18. PubMed ID: 2980710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen retrieval and primary antibody type affect sensitivity but not specificity of CD117 immunohistochemistry.
    Wong NA; Melegh Z
    Histopathology; 2009 Apr; 54(5):529-38. PubMed ID: 19413635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the Way to New Horizons: Telemedicine in Oncology.
    Schlag PM
    Oncologist; 1997; 2(2):III-IV. PubMed ID: 10388041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
    Esheba GE; Pate LL; Longacre TA
    Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 397.